Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma is common among men as compared to women and also arises commonly with growing age.

The market is mainly driven by the significant applications of Multiple Myeloma Therapeutics in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Multiple Myeloma Therapeutics market. Chemotherapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Multiple Myeloma Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Multiple Myeloma Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Multiple Myeloma Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Multiple Myeloma Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Multiple Myeloma Therapeutics covered in this report include Janssen Biotech, Inc., Bristol-Myers Squibb, Novartis AG, Bristol-Myers Squibb Company, Millennium Pharmaceuticals, Celgene Corporation, Kesios Therapeutics Limited, Amgene, Inc. and Genzyme Corporation, etc.

The global Multiple Myeloma Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Janssen Biotech, Inc.

Bristol-Myers Squibb

Novartis AG

Bristol-Myers Squibb Company

Millennium Pharmaceuticals

Celgene Corporation

Kesios Therapeutics Limited

Amgene, Inc.

Genzyme Corporation

Juno Therapeutics

Scope of Multiple Myeloma Therapeutics - Market Report

Report Metric	Details
Report Name	Multiple Myeloma Therapeutics - Market
Forecasted market size in 2029	US$ 55870 million
CAGR	10.6%
Forecasted years	2023 - 2029
Global Multiple Myeloma Therapeutics market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Multiple Myeloma Therapeutics market, Segment by Type:	Chemotherapy Radiation Stem Cell Transplant Other Supportive Treatments
Global Multiple Myeloma Therapeutics market, by Application	Hospitals Clinics Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Multiple Myeloma Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Multiple Myeloma Therapeutics - Market size in 2029?

Ans: The Multiple Myeloma Therapeutics - Market size in 2029 will be US$ 55870 million.

What are the Application segmentation covered in the Multiple Myeloma Therapeutics - Market report?

Ans: The Applications covered in the Multiple Myeloma Therapeutics - Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Multiple Myeloma Therapeutics - Market report?

Ans: The Types covered in the Multiple Myeloma Therapeutics - Market report are Chemotherapy, Radiation, Stem Cell Transplant, Other Supportive Treatments

1 Market Overview of Multiple Myeloma Therapeutics

1.1 Multiple Myeloma Therapeutics Market Overview

1.1.1 Multiple Myeloma Therapeutics Product Scope

1.1.2 Multiple Myeloma Therapeutics Market Status and Outlook

1.2 Global Multiple Myeloma Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Multiple Myeloma Therapeutics Market Size by Region (2018-2029)

1.4 Global Multiple Myeloma Therapeutics Historic Market Size by Region (2018-2023)

1.5 Global Multiple Myeloma Therapeutics Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Multiple Myeloma Therapeutics Market Size (2018-2029)

1.6.1 North America Multiple Myeloma Therapeutics Market Size (2018-2029)

1.6.2 Europe Multiple Myeloma Therapeutics Market Size (2018-2029)

1.6.3 Asia-Pacific Multiple Myeloma Therapeutics Market Size (2018-2029)

1.6.4 Latin America Multiple Myeloma Therapeutics Market Size (2018-2029)

1.6.5 Middle East & Africa Multiple Myeloma Therapeutics Market Size (2018-2029)

2 Multiple Myeloma Therapeutics Market by Type

2.1 Introduction

2.1.1 Chemotherapy

2.1.2 Radiation

2.1.3 Stem Cell Transplant

2.1.4 Other Supportive Treatments

2.2 Global Multiple Myeloma Therapeutics Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Multiple Myeloma Therapeutics Historic Market Size by Type (2018-2023)

2.2.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Multiple Myeloma Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Multiple Myeloma Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Multiple Myeloma Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Multiple Myeloma Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Multiple Myeloma Therapeutics Revenue Breakdown by Type (2018-2029)

3 Multiple Myeloma Therapeutics Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Clinics

3.1.3 Others

3.2 Global Multiple Myeloma Therapeutics Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Multiple Myeloma Therapeutics Historic Market Size by Application (2018-2023)

3.2.2 Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Multiple Myeloma Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Multiple Myeloma Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Multiple Myeloma Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Multiple Myeloma Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Multiple Myeloma Therapeutics Revenue Breakdown by Application (2018-2029)

4 Multiple Myeloma Therapeutics Competition Analysis by Players

4.1 Global Multiple Myeloma Therapeutics Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2022)

4.3 Date of Key Players Enter into Multiple Myeloma Therapeutics Market

4.4 Global Top Players Multiple Myeloma Therapeutics Headquarters and Area Served

4.5 Key Players Multiple Myeloma Therapeutics Product Solution and Service

4.6 Competitive Status

4.6.1 Multiple Myeloma Therapeutics Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Janssen Biotech, Inc.

5.1.1 Janssen Biotech, Inc. Profile

5.1.2 Janssen Biotech, Inc. Main Business

5.1.3 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Products, Services and Solutions

5.1.4 Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.1.5 Janssen Biotech, Inc. Recent Developments

5.2 Bristol-Myers Squibb

5.2.1 Bristol-Myers Squibb Profile

5.2.2 Bristol-Myers Squibb Main Business

5.2.3 Bristol-Myers Squibb Multiple Myeloma Therapeutics Products, Services and Solutions

5.2.4 Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.2.5 Bristol-Myers Squibb Recent Developments

5.3 Novartis AG

5.3.1 Novartis AG Profile

5.3.2 Novartis AG Main Business

5.3.3 Novartis AG Multiple Myeloma Therapeutics Products, Services and Solutions

5.3.4 Novartis AG Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.3.5 Bristol-Myers Squibb Company Recent Developments

5.4 Bristol-Myers Squibb Company

5.4.1 Bristol-Myers Squibb Company Profile

5.4.2 Bristol-Myers Squibb Company Main Business

5.4.3 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Products, Services and Solutions

5.4.4 Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.4.5 Bristol-Myers Squibb Company Recent Developments

5.5 Millennium Pharmaceuticals

5.5.1 Millennium Pharmaceuticals Profile

5.5.2 Millennium Pharmaceuticals Main Business

5.5.3 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Products, Services and Solutions

5.5.4 Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.5.5 Millennium Pharmaceuticals Recent Developments

5.6 Celgene Corporation

5.6.1 Celgene Corporation Profile

5.6.2 Celgene Corporation Main Business

5.6.3 Celgene Corporation Multiple Myeloma Therapeutics Products, Services and Solutions

5.6.4 Celgene Corporation Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.6.5 Celgene Corporation Recent Developments

5.7 Kesios Therapeutics Limited

5.7.1 Kesios Therapeutics Limited Profile

5.7.2 Kesios Therapeutics Limited Main Business

5.7.3 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Products, Services and Solutions

5.7.4 Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.7.5 Kesios Therapeutics Limited Recent Developments

5.8 Amgene, Inc.

5.8.1 Amgene, Inc. Profile

5.8.2 Amgene, Inc. Main Business

5.8.3 Amgene, Inc. Multiple Myeloma Therapeutics Products, Services and Solutions

5.8.4 Amgene, Inc. Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.8.5 Amgene, Inc. Recent Developments

5.9 Genzyme Corporation

5.9.1 Genzyme Corporation Profile

5.9.2 Genzyme Corporation Main Business

5.9.3 Genzyme Corporation Multiple Myeloma Therapeutics Products, Services and Solutions

5.9.4 Genzyme Corporation Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.9.5 Genzyme Corporation Recent Developments

5.10 Juno Therapeutics

5.10.1 Juno Therapeutics Profile

5.10.2 Juno Therapeutics Main Business

5.10.3 Juno Therapeutics Multiple Myeloma Therapeutics Products, Services and Solutions

5.10.4 Juno Therapeutics Multiple Myeloma Therapeutics Revenue (US$ Million) & (2018-2023)

5.10.5 Juno Therapeutics Recent Developments

6 North America

6.1 North America Multiple Myeloma Therapeutics Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Multiple Myeloma Therapeutics Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Multiple Myeloma Therapeutics Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Multiple Myeloma Therapeutics Market Dynamics

11.1 Multiple Myeloma Therapeutics Industry Trends

11.2 Multiple Myeloma Therapeutics Market Drivers

11.3 Multiple Myeloma Therapeutics Market Challenges

11.4 Multiple Myeloma Therapeutics Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Janssen Biotech Inc

Bristol–Myers Squibb

Novartis

Bristol Myers Squibb Company

Millennium Pharmaceuticals

Celgene Corporation

Kesios Therapeutics Limited

Amgene

Genzyme Corporation

Juno Therapeutics

List of Tables

Table 1. Global Market Multiple Myeloma Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Multiple Myeloma Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Multiple Myeloma Therapeutics Market Size Share by Region (2018-2023)

Table 4. Global Multiple Myeloma Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Multiple Myeloma Therapeutics Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Multiple Myeloma Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Multiple Myeloma Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2023)

Table 9. Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2024-2029)

Table 11. North America Multiple Myeloma Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Multiple Myeloma Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Multiple Myeloma Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Multiple Myeloma Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Multiple Myeloma Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Multiple Myeloma Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Multiple Myeloma Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Multiple Myeloma Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2023)

Table 24. Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2024-2029)

Table 26. North America Multiple Myeloma Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Multiple Myeloma Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Multiple Myeloma Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Multiple Myeloma Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Multiple Myeloma Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Multiple Myeloma Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Multiple Myeloma Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Multiple Myeloma Therapeutics Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Multiple Myeloma Therapeutics Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2022)

Table 39. Date of Key Players Enter into Multiple Myeloma Therapeutics Market

Table 40. Global Multiple Myeloma Therapeutics Key Players Headquarters and Area Served

Table 41. Multiple Myeloma Therapeutics Product Solution and Service

Table 42. Global Multiple Myeloma Therapeutics Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Janssen Biotech, Inc. Basic Information List

Table 45. Janssen Biotech, Inc. Description and Business Overview

Table 46. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Products, Services and Solutions

Table 47. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Janssen Biotech, Inc. (2018-2023)

Table 48. Janssen Biotech, Inc. Recent Developments

Table 49. Bristol-Myers Squibb Basic Information List

Table 50. Bristol-Myers Squibb Description and Business Overview

Table 51. Bristol-Myers Squibb Multiple Myeloma Therapeutics Products, Services and Solutions

Table 52. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Bristol-Myers Squibb (2018-2023)

Table 53. Bristol-Myers Squibb Recent Developments

Table 54. Novartis AG Basic Information List

Table 55. Novartis AG Description and Business Overview

Table 56. Novartis AG Multiple Myeloma Therapeutics Products, Services and Solutions

Table 57. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Novartis AG (2018-2023)

Table 58. Novartis AG Recent Developments

Table 59. Bristol-Myers Squibb Company Basic Information List

Table 60. Bristol-Myers Squibb Company Description and Business Overview

Table 61. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Products, Services and Solutions

Table 62. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Bristol-Myers Squibb Company (2018-2023)

Table 63. Bristol-Myers Squibb Company Recent Developments

Table 64. Millennium Pharmaceuticals Basic Information List

Table 65. Millennium Pharmaceuticals Description and Business Overview

Table 66. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Products, Services and Solutions

Table 67. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Millennium Pharmaceuticals (2018-2023)

Table 68. Millennium Pharmaceuticals Recent Developments

Table 69. Celgene Corporation Basic Information List

Table 70. Celgene Corporation Description and Business Overview

Table 71. Celgene Corporation Multiple Myeloma Therapeutics Products, Services and Solutions

Table 72. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Celgene Corporation (2018-2023)

Table 73. Celgene Corporation Recent Developments

Table 74. Kesios Therapeutics Limited Basic Information List

Table 75. Kesios Therapeutics Limited Description and Business Overview

Table 76. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Products, Services and Solutions

Table 77. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Kesios Therapeutics Limited (2018-2023)

Table 78. Kesios Therapeutics Limited Recent Developments

Table 79. Amgene, Inc. Basic Information List

Table 80. Amgene, Inc. Description and Business Overview

Table 81. Amgene, Inc. Multiple Myeloma Therapeutics Products, Services and Solutions

Table 82. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Amgene, Inc. (2018-2023)

Table 83. Amgene, Inc. Recent Developments

Table 84. Genzyme Corporation Basic Information List

Table 85. Genzyme Corporation Description and Business Overview

Table 86. Genzyme Corporation Multiple Myeloma Therapeutics Products, Services and Solutions

Table 87. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Genzyme Corporation (2018-2023)

Table 88. Genzyme Corporation Recent Developments

Table 89. Juno Therapeutics Basic Information List

Table 90. Juno Therapeutics Description and Business Overview

Table 91. Juno Therapeutics Multiple Myeloma Therapeutics Products, Services and Solutions

Table 92. Revenue (US$ Million) in Multiple Myeloma Therapeutics Business of Juno Therapeutics (2018-2023)

Table 93. Juno Therapeutics Recent Developments

Table 94. North America Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 95. North America Multiple Myeloma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 96. Europe Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 97. Europe Multiple Myeloma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 98. Asia-Pacific Multiple Myeloma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 99. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 100. Asia-Pacific Multiple Myeloma Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 101. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Region (2018-2023)

Table 102. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Region (2024-2029)

Table 103. Latin America Multiple Myeloma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 104. Latin America Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 105. Latin America Multiple Myeloma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 106. Middle East & Africa Multiple Myeloma Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 107. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 108. Middle East & Africa Multiple Myeloma Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 109. Multiple Myeloma Therapeutics Market Trends

Table 110. Multiple Myeloma Therapeutics Market Drivers

Table 111. Multiple Myeloma Therapeutics Market Challenges

Table 112. Multiple Myeloma Therapeutics Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Multiple Myeloma Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Multiple Myeloma Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Multiple Myeloma Therapeutics Market Share by Regions: 2022 VS 2029

Figure 4. Global Multiple Myeloma Therapeutics Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Multiple Myeloma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Multiple Myeloma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Multiple Myeloma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Multiple Myeloma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Multiple Myeloma Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Chemotherapy

Figure 11. Global Chemotherapy Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Radiation

Figure 13. Global Radiation Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Stem Cell Transplant

Figure 15. Global Stem Cell Transplant Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Other Supportive Treatments

Figure 17. Global Other Supportive Treatments Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Global Multiple Myeloma Therapeutics Market Size Share by Type: 2022 & 2029

Figure 19. North America Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2029)

Figure 20. Europe Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2029)

Figure 21. Asia-Pacific Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2029)

Figure 22. Latin America Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2029)

Figure 23. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Type (2018-2029)

Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Global Multiple Myeloma Therapeutics Market Size Share by Application: 2022 & 2029

Figure 28. North America Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2029)

Figure 29. Europe Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2029)

Figure 30. Asia-Pacific Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2029)

Figure 31. Latin America Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2029)

Figure 32. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Application (2018-2029)

Figure 33. Multiple Myeloma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 34. Global Top 5 and Top 10 Players Multiple Myeloma Therapeutics Market Share in 2022

Figure 35. North America Multiple Myeloma Therapeutics Market Share by Country (2018-2029)

Figure 36. U.S. Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 37. Canada Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 38. Germany Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 39. France Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 40. U.K. Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 41. Italy Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 42. Russia Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 43. Nordic Countries Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 44. Asia-Pacific Multiple Myeloma Therapeutics Market Share by Region (2018-2029)

Figure 45. China Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 46. Japan Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 47. South Korea Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 48. Southeast Asia Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 49. India Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 50. Australia Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 51. Latin America Multiple Myeloma Therapeutics Market Share by Country (2018-2029)

Figure 52. Mexico Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 53. Brazil Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 54. Middle East & Africa Multiple Myeloma Therapeutics Market Share by Country (2018-2029)

Figure 55. Turkey Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 56. Saudi Arabia Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 57. UAE Multiple Myeloma Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 58. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pediatric Cardiac Tumor Diagnostic Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G6046

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Interventional Oncology Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-20U7613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions